Drugs / SHR-9839(sc)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07059221 | Jul 2025 → Mar 2027 expected | head and neck squamous cell carcinoma | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHR-9839(sc) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07059221 ↗ |
| Route | Subcutaneous | “Administration by Subcutaneous injection” NCT07059221 ↗ |